We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 284 start-ups with an aggregate funding of $11.9b. The average funding per company in this subset is $172.2m.
Last update to the database: Feb 18, 2025. See changelog.
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
5
Funding Rounds
$390.0m
Money raised
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
10
Funding Rounds
$930.0m
Money raised
Leo Cancer Care is a company developing upright radiotherapy solutions.
1
Funding Rounds
$25.3m
Money raised
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
4
Funding Rounds
$1.8b
Money raised
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
8
Funding Rounds
$71.3m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
6
Funding Rounds
$399.8m
Money raised
Flatiron Health is a startup that organizes real-time oncology data to help cancer patients and doctors.
3
Funding Rounds
$313.0m
Money raised
Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.
10
Funding Rounds
$410.0m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$190.5m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
6
Funding Rounds
$15.8m
Money raised
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
2
Funding Rounds
$13.8m
Money raised
Mission Bio is a South San Francisco based company that develops single-cell DNA analysis and precision genomics.
4
Funding Rounds
$140.0m
Money raised
Deep Lens is an Artificial Intelligence company matching patients with clinical trials.
3
Funding Rounds
$31.2m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
8
Funding Rounds
$967.6m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
2
Funding Rounds
$67.5m
Money raised
Athelas is a company developing blood testing device that utilizes deep learning and computer vision.
5
Funding Rounds
$155.6m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
2
Funding Rounds
$18.1m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
4
Funding Rounds
$743.2m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.
7
Funding Rounds
$65.4m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Breathalyzer device maker for the early detection of cancer.
8
Funding Rounds
$160.3m
Money raised
MiRXES is a Singapore-based biotechnology company specializing in microRNA-based diagnostics founded in 2014.
1
Funding Rounds
$77.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
5
Funding Rounds
$425.0m
Money raised
Faeth Therapeutics is a start-up that focuses on using nutrition and metabolism to fight cancer.
3
Funding Rounds
$67.0m
Money raised
An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.
2
Funding Rounds
$11.5m
Money raised
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy.
4
Funding Rounds
$96.5m
Money raised
CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.
1
Funding Rounds
$150.0k
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.
2
Funding Rounds
$58.4m
Money raised
A biomedical company in United Kingdom that develops vaccines and vaccine development technology
2
Funding Rounds
$37.5m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
2
Funding Rounds
$386.0m
Money raised
Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.
1
Funding Rounds
DCPrime is a biotechnology company developing cancer immunotherapies.
5
Funding Rounds
$26.0m
Money raised
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
2
Funding Rounds
$195.5m
Money raised
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
1
Funding Rounds
A&G Pharmaceutical is a Columbia, Maryland-based theranostics company developing personalized cancer therapeutics through cancer-specific monoclonal antibodies.
1
Funding Rounds
$2.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
3
Funding Rounds
$32.5m
Money raised
Epic Sciences is a San Diego-based company founded in 2008 by Jorge Nieva, David Nelson and Peter Kuhn.
7
Funding Rounds
$195.5m
Money raised
A biotechnology company developing t-cell immunotherapies therapies for the treatment of cancer. The company is headquartered in Singapore, and was founded by Malcolm Brenner and Andrew Khoo in 2011.
1
Funding Rounds
$80.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$7.0m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$42.2m
Money raised
Small Molecules
4
Funding Rounds
$270.0m
Money raised
Biomedical Artificial Intelligence company developing products for early cancer detection in the breast.
1
Funding Rounds
$22.0m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
3
Funding Rounds
$50.6m
Money raised
A company developing immune therapies for cancer and related diseases
2
Funding Rounds
$33.8m
Money raised
Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.
1
Funding Rounds
$24.0m
Money raised
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.
8
Funding Rounds
$59.9m
Money raised
Caris Life Sciences is a medical diagnostics company developing molecular profiling combined with artificial intelligence founded in 1996 by David D. Halbert.
6
Funding Rounds
$633.0m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
2
Funding Rounds
$33.9m
Money raised
XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.
2
Funding Rounds
$173.0k
Money raised
Crown bioscience is a company that is focused on research, drug discovery and development for the treatment of cancer and diabetes.
6
Funding Rounds
$62.1m
Money raised
A biotechnology company developing molecular-based diagnostic, prognostic, and predictive medical tests designed to help healthcare practitioners treat cancer.
1
Funding Rounds
$32.0m
Money raised
Juno Therapeutics is a biopharmaceutical company developing medicines for the treatment of serious diseases.
6
Funding Rounds
$382.1m
Money raised
Canopy is a Draper, Utah-based company founded in 2014.
6
Funding Rounds
$122.8m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
2
Funding Rounds
$2.6m
Money raised
SEngine Precision Medicine is a precision medicine company founded by Brady Bernard, Carla Grandori, Christopher Kemp, and VK Gadi.
2
Funding Rounds
$8.1m
Money raised
Iterative Health is a Cambridge, Massachusetts-based company that provides gastroenterologists with machine learning-powered diagnostic tools to aid in the prevention of colon cancer and improve patient outcomes.
5
Funding Rounds
$187.0m
Money raised
Heidelberg Pharma is a Ladenburg-based pre-clinical drug discovery and development company working on developing anti-cancer and anti-inflammatory drugs.
2
Funding Rounds
$51.1m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$200.0m
Money raised
HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
2
Funding Rounds
$128.2m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
3
Funding Rounds
$13.2m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$35.0m
Money raised
Cancer drugs that target specific types of poly ADP-ribose polymerase
3
Funding Rounds
$190.2m
Money raised